A single gene encoding a 6-desaturase (FADS2) has been isolated and characterized in mammalian species. This 6-desaturase plays a major role in the biosynthesis of PUFAs (polyunsaturated fatty acids). It catalyses the rate-limiting desaturation of linoleic acid (C 18:2 n − 6) and α-linolenic acid (C 18:3 n − 3) required for the biosynthesis of long-chain PUFAs. Moreover, recent studies have provided strong evidence that this 6-desaturase also acts on 24-carbon PUFAs of both the n − 6 and n − 3 series. Another substrate of this 6-desaturase has been identified through complementary works from different investigators. This 6-desaturase acts on a saturated fatty acid, palmitic acid (C 16:0 ), leading to the newly characterized biosynthesis of hexadecenoic acid (C 16:1 n − 10) or sapienate.
Introduction
In mammals, at least three distinct desaturase enzymes introduce double bonds at the 9, 6 and 5 positions along the carbon fatty-acyl chains of some fatty acid substrates. 9-Desaturase, also named SCD (stearoyl-CoA desaturase), catalyses the rate-limiting step in the biosynthesis of monounsatured fatty acids. In mouse, four isoforms of SCD have been identified [1] . In human, a single SCD gene which is highly similar to mouse genes has been cloned and characterized [2] .
6-and 5-desaturases govern rate-limiting steps in the biosynthesis of long-chain PUFAs (polyunsaturated fatty acids). The biosynthesis of long-chain PUFAs from C 18:2 n − 6 and C 18:3 n − 3 involves successive desaturation and elongation steps. The first step is the 6-desaturation of the 18-carbon precursors of the n − 6 and n − 3 series. The 6-desaturase cloned from human [3] and rodents [3, 4] , i.e. FADS2 [5] , was shown to catalyse this initial reaction. The second 6-desaturation step from C 24:4 n − 6 to C 24:5 n − 6 and from C 24:5 n − 3 to C 24:6 n − 3, initially described by Sprecher and co-workers [6] , had to be further explored.
More recently, a palmitoyl-CoA 6-desaturase was reported for the first time to be present in mammals [7] . This finding has emerged from detailed study of the prepucial gland of mice with targeted disruption of SCD1, a major isoform of 9-desaturase. In this work, the impairment of C 16:1 n − 7 biosynthesis in SCD1 −/− mice correlated with an increased level of C 16:1 n − 10. The palmitoyl-CoA 6-desaturase responsible for this increased biosynthesis was not identified.
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and on palmitic acid. Together with results obtained by other investigators, our data demonstrate a remarkable diversity of 6-desaturase substrates.
6-Desaturase acts twice in long-chain PUFA biosynthesis
In long-chain PUFA biosynthesis the conversion step from C 22:4 n − 6 to C 22:5 n − 6 and from C 22:5 n − 3 to C 22:6 n − 3 has remained controversial for years. One opinion is that this step depends on a microsomal 4-desaturation [8] . Another theory proposed by Sprecher and co-workers [6] is a 4-desaturase-independent pathway including two successive elongations producing 24-carbon fatty acid intermediates, followed by a 6-desaturation of these 24-carbon fatty acids in the microsomes, and a final chain-shortening in the peroxisomes.
We addressed the possible role of the rat 6-desaturase, known to act on C 18:2 n − 6 and on C 18:3 n − 3, in the conversion of C 24:4 n − 6 to C 24:5 n − 6 and C 24:5 n − 3 to C 24:6 n − 3. To investigate this hypothesis, we transiently expressed rat 6-desaturase [9] in COS-7 cells. We provided strong evidence in these mammalian cells that a high level of rat 6-desaturase expression was correlated with a significant activity on both 18-and 24-carbon PUFAs of the n − 3 series. Our results also suggested a similar mechanism in the n − 6 series. In a yeast expression model, de Antueno et al. [10] obtained similar results with the human 6-desaturase, homologue to the rat 6-desaturase we studied.
SCD1 disruption reveals a new substrate of 6-desaturase
Recent findings, by Ntambi and Miyazaki [11] , using a mouse model with disruption of SCD1 gene expression have highlighted the role of de novo oleate production and the physiological roles of SCD1. Their characterization of this mouse model also revealed for the first time the presence of a palmitoyl-CoA 6-desaturation in animals [7] . They demonstrated a 6-desaturation in the preputial gland, a sebaceous gland of the urogenital tract, of SCD1 −/− mice in which C 16:1 n − 10 content was markedly increased.
To investigate the putative involvement of 6-desaturase (FADS2) in this synthesis, we incubated COS-7 cells expressing rat 6-desaturase with palmitic acid (C 16:0 ). Transfected cells were able to synthesize C 16:1 n − 10, while non-transfected cells did not produce any C 16:1 n − 10. Thus rat 6-desaturase which acts on the 18-and 24-carbon PUFAs (FADS2) is also able to catalyse palmitic acid 6-desaturation [12] . We also performed similar incubation of COS-7 cells expressing both 6-desaturase and SCD1 9-desaturase with palmitic acid. In these experimental conditions, we showed that conversion of C 16:0 to C 16:1 n − 10 was limited while the conversion of C 16:0 to C 16:1 n − 7 was greatly increased. Thus we propose that C 16:1 n − 10 biosynthesis may occur in tissues with a high level of 6-desaturase (FADS2) expression and a low level of SCD1 expression, such as in human sebaceous glands [13] . Consistent with this proposal, the palmitoylCoA 6-desaturase identified in SCD1 −/− mice is likely to be FADS2, which was detectable at similar levels in the preputial glands of both wild-type and SCD1
−/− mice. The lack of SCD1 may lead to a tissue-specific adaptative increase in C 16:1 n − 10, preventing palmitate accumulation.
A new biological significance of 6-desaturase activity?
Ge et al. [13] also identified human FADS2 as the major fatty acid desaturase in human sebaceous glands capable of catalysing palmitate (C 16:0 ) 6-desaturation to sapienate (C 16:1 n − 10). In human, sapienate is the major fatty acid in sebaceous gland [14] . Thus these authors proposed that FADS2 plays an important role in sebum production, possibly sebocyte differentiation in human and skin homoeostasis. An inherited deficiency in 6-desaturase (FADS2) has been reported in the skin fibroblasts of a young patient [15] . Shortly after her birth, abnormal serum C 20:4 n − 6 and C 22:6 n − 3 levels were detected and a severe clinical picture, including corneal ulceration, growth retardation, feeding intolerance and skin abnormalities, was reported [15] . n − 6 and n − 3 PUFA dietary supplementation of this young patient led to amelioration of her growth retardation. However, some skin, nail and hair abnormalities were not sensitive to this n − 6 and n − 3 PUFA dietary supplementation. If C 16:1 n − 10 biosynthesis is important for human skin, a C 16:1 n − 10 supply should be considered in the case of altered 6-desaturase activity.
Conclusion
The 6-desaturase is considered as a key enzyme required for numerous vital functions involving distinct PUFAs and other PUFA-derived bioactive lipids. It seems that the biological importance of 6-desaturase activity should also be considered for its newly identified role in the control of the biosynthesis of a monoenoic fatty acid (C 16:1 n − 10), particularly in tissues with low 9-desaturase activity.
